The graft-versus-lymphoma effect: Clinical review and future opportunities

B. W. Butcher, Robert H. Collins

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Numerous lines of preclinical and clinical evidence support the existence of a graft-versus-leukemia effect, but less evidence supporting a comparable graft-versus-lymphoma effect exists. We review here current clinical data addressing the graft-versus-lymphoma effect, including comparisons of autologous, syngeneic, and allogeneic transplantation; responses to immunomodulation; and responses to nonmyeloablative stem cell transplantation. Despite several limitations of the data, we believe that there is sufficient evidence suggesting a significant graft-versus-lymphoma effect. In addition, we discuss approaches for clinical management of lymphoma patients, opportunities for mechanistic studies afforded by donor leukocyte infusions and nonmyeloablative transplantation, and suggestions for clinical studies to further define the magnitude and applicability of the graft-versus-lymphoma effect.

Original languageEnglish (US)
Pages (from-to)1-17
Number of pages17
JournalBone Marrow Transplantation
Volume36
Issue number1
DOIs
StatePublished - Jul 2005

Fingerprint

Lymphoma
Transplants
Isogeneic Transplantation
Immunomodulation
Autologous Transplantation
Homologous Transplantation
Stem Cell Transplantation
Leukemia
Leukocytes
Transplantation
Tissue Donors

Keywords

  • Donor leukocyte infusion (DLI)
  • Graft-versus-lymphoma effect (GVL)
  • Hodgkin's disease (HD)
  • Non-Hodgkin's lymphoma (NHL)
  • Non-myeloablative stem cell transplantation (NST)

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

The graft-versus-lymphoma effect : Clinical review and future opportunities. / Butcher, B. W.; Collins, Robert H.

In: Bone Marrow Transplantation, Vol. 36, No. 1, 07.2005, p. 1-17.

Research output: Contribution to journalArticle

@article{2e1cbf8bae32430bada4954b309fa825,
title = "The graft-versus-lymphoma effect: Clinical review and future opportunities",
abstract = "Numerous lines of preclinical and clinical evidence support the existence of a graft-versus-leukemia effect, but less evidence supporting a comparable graft-versus-lymphoma effect exists. We review here current clinical data addressing the graft-versus-lymphoma effect, including comparisons of autologous, syngeneic, and allogeneic transplantation; responses to immunomodulation; and responses to nonmyeloablative stem cell transplantation. Despite several limitations of the data, we believe that there is sufficient evidence suggesting a significant graft-versus-lymphoma effect. In addition, we discuss approaches for clinical management of lymphoma patients, opportunities for mechanistic studies afforded by donor leukocyte infusions and nonmyeloablative transplantation, and suggestions for clinical studies to further define the magnitude and applicability of the graft-versus-lymphoma effect.",
keywords = "Donor leukocyte infusion (DLI), Graft-versus-lymphoma effect (GVL), Hodgkin's disease (HD), Non-Hodgkin's lymphoma (NHL), Non-myeloablative stem cell transplantation (NST)",
author = "Butcher, {B. W.} and Collins, {Robert H.}",
year = "2005",
month = "7",
doi = "10.1038/sj.bmt.1705008",
language = "English (US)",
volume = "36",
pages = "1--17",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - The graft-versus-lymphoma effect

T2 - Clinical review and future opportunities

AU - Butcher, B. W.

AU - Collins, Robert H.

PY - 2005/7

Y1 - 2005/7

N2 - Numerous lines of preclinical and clinical evidence support the existence of a graft-versus-leukemia effect, but less evidence supporting a comparable graft-versus-lymphoma effect exists. We review here current clinical data addressing the graft-versus-lymphoma effect, including comparisons of autologous, syngeneic, and allogeneic transplantation; responses to immunomodulation; and responses to nonmyeloablative stem cell transplantation. Despite several limitations of the data, we believe that there is sufficient evidence suggesting a significant graft-versus-lymphoma effect. In addition, we discuss approaches for clinical management of lymphoma patients, opportunities for mechanistic studies afforded by donor leukocyte infusions and nonmyeloablative transplantation, and suggestions for clinical studies to further define the magnitude and applicability of the graft-versus-lymphoma effect.

AB - Numerous lines of preclinical and clinical evidence support the existence of a graft-versus-leukemia effect, but less evidence supporting a comparable graft-versus-lymphoma effect exists. We review here current clinical data addressing the graft-versus-lymphoma effect, including comparisons of autologous, syngeneic, and allogeneic transplantation; responses to immunomodulation; and responses to nonmyeloablative stem cell transplantation. Despite several limitations of the data, we believe that there is sufficient evidence suggesting a significant graft-versus-lymphoma effect. In addition, we discuss approaches for clinical management of lymphoma patients, opportunities for mechanistic studies afforded by donor leukocyte infusions and nonmyeloablative transplantation, and suggestions for clinical studies to further define the magnitude and applicability of the graft-versus-lymphoma effect.

KW - Donor leukocyte infusion (DLI)

KW - Graft-versus-lymphoma effect (GVL)

KW - Hodgkin's disease (HD)

KW - Non-Hodgkin's lymphoma (NHL)

KW - Non-myeloablative stem cell transplantation (NST)

UR - http://www.scopus.com/inward/record.url?scp=21744446745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21744446745&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1705008

DO - 10.1038/sj.bmt.1705008

M3 - Article

C2 - 15895112

AN - SCOPUS:21744446745

VL - 36

SP - 1

EP - 17

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 1

ER -